Since SUSD2 is a membrane protein that is abundant in 80% of patient BCa samples, further study of this pathway may lead to the identification of novel therapeutic targets to inhibit the function of SUSD2 and ultimately impede cancer metastasis. This evidence concerns the gene SUSD2 and cancer.